2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-06-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11989020 2023-06-01 2024-05-31 11989020 2024-05-31 11989020 2023-05-31 11989020 2022-06-01 2023-05-31 11989020 2023-05-31 11989020 2022-05-31 11989020 bus:Director1 2023-06-01 2024-05-31 11989020 core:WithinOneYear 2024-05-31 11989020 core:WithinOneYear 2023-05-31 11989020 bus:Micro-entities 2023-06-01 2024-05-31 11989020 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 11989020 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 11989020 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 11989020 bus:FullAccounts 2023-06-01 2024-05-31
COMPANY REGISTRATION NUMBER: 11989020
BERKSHIRE NEPHROLOGY LIMITED
Filleted Unaudited Financial Statements
31 May 2024
BERKSHIRE NEPHROLOGY LIMITED
Statement of Financial Position
31 May 2024
2024
2023
£
£
Current assets
59,476
48,740
Creditors: amounts falling due within one year
25,320
22,487
--------
--------
Net current assets
34,156
26,253
--------
--------
Total assets less current liabilities
34,156
26,253
Accruals and deferred income
750
750
--------
--------
33,406
25,503
--------
--------
Capital and reserves
33,406
25,503
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 28 May 2025 , and are signed on behalf of the board by:
Dr B Alchi
Director
Company registration number: 11989020
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Ruddlesway, Windsor, Berkshire, SL4 5SF.